Performing extensive pharmacokinetic profiling of this class of molecules, coupled to chemical optimization efforts and/or innovative ways of delivery to the central nervous system, could provide effective therapeutic strategies for prion diseases, and possibly other neurodegenerative disorders linked to the toxicity-transducing activity of PrPC. Here, PRNP is linked to prion disease.